AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)
$1.41 0 (0%)
Analysed AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) News Sources
Akebia Therapeutics Leads The Pack Of 3 Promising Penny Stocks
13-04-2026
yahoo.com
Akebia Therapeutics Announces First Participants Dosed in Phase 1 Clinical Trial of AKB-9090
13-04-2026
yahoo.com
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium
07-04-2026
yahoo.com
How The Akebia Therapeutics (AKBA) Narrative Is Shifting After Vafseo Revenue And Protocol Updates
06-04-2026
yahoo.com
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02-04-2026
yahoo.com
Akebia Therapeutics R&D Day: Vafseo Growth Plan, Praliciguat Phase 2, New Kidney Pipeline Targets
02-04-2026
marketbeat.com
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
01-04-2026
yahoo.com
Guardian Pharmacy (GRDN) Soars 9.1%: Is Further Upside Left in the Stock?
31-03-2026
yahoo.com
Is Akebia Therapeutics (AKBA) One of the Best Penny Stocks to Buy
31-03-2026
yahoo.com
Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026
19-03-2026
yahoo.com
What is the current price of AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)?
The current price of AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) is $1.41.
AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) absolute price change since previous trading day?
The absolute price change of AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) since the previous trading day is $0.
AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) percentage price change since previous trading day?
The percentage price change of AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) since the previous trading day is 0%.
What is the most recent average sentiment score for AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)?
The most recent average sentiment score for AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) is 88 out of 100.
What is the most recent average sentiment for AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)?
The most recent sentiment for AKEBIA THERAPEUTICS INC (AKBA:NASDAQ) is .
SEC-8K** Filing Available For AKEBIA THERAPEUTICS INC (AKBA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.